Advanced search
Publication Cover
Patient Preference and Adherence Volume 13, 2019 - Issue
Submit an article Journal homepage
105
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort

Norbert Königsdorfer1 Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M), Ludwig-Maximilians-Universität München, Munich80336, GermanyView further author information
,
Rudolf A Jörres1 Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M), Ludwig-Maximilians-Universität München, Munich80336, GermanyORCID Iconhttps://orcid.org/0000-0002-9782-1117View further author information
ORCID Icon,
Sandra Söhler2 ASCONET Study Coordination Office, University of Marburg, Marburg35043, GermanyORCID Iconhttps://orcid.org/0000-0001-5851-1872View further author information
ORCID Icon,
Tobias Welte3 Department of Pneumology, Hannover Medical School, Hannover30625, GermanyView further author information
,
Jürgen Behr4 Department of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich80336, GermanyView further author information
,
Joachim H Ficker5 Department of Respiratory Medicine, Allergology and Sleep Medicine, General Hospital Nuernberg, Paracelsus Medical University, Nuernberg, GermanyORCID Iconhttps://orcid.org/0000-0002-7175-5852View further author information
ORCID Icon,
Robert Bals6 Department of Internal Medicine V, Pneumology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital, Homburg66424, GermanyView further author information
,
Henrik Watz7 Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research, Grosshansdorf22927, GermanyView further author information
,
Johanna I Lutter8 Institute of Health Economics and Health Care Management, Helmholtz Zentrum München GmbH – German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Munich85764, GermanyORCID Iconhttps://orcid.org/0000-0002-0159-4862View further author information
ORCID Icon,
Tanja Lucke1 Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M), Ludwig-Maximilians-Universität München, Munich80336, GermanyORCID Iconhttps://orcid.org/0000-0001-9466-8420View further author information
ORCID Icon,
Frank Biertz9 Institute for Biostatistics, Hannover Medical School, Hannover30625, GermanyORCID Iconhttps://orcid.org/0000-0003-0686-6123View further author information
ORCID Icon,
Peter Alter10 Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg35043, GermanyORCID Iconhttps://orcid.org/0000-0002-2115-1743View further author information
ORCID Icon,
Claus F Vogelmeier10 Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg35043, GermanyView further author information
&
Kathrin Kahnert4 Department of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich80336, GermanyCorrespondence[email protected]
View further author information
 show all
Pages 1711-1721 | Published online: 10 Oct 2019

References

  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49. doi:10.1183/13993003.00214-2017
  • Wacker ME, Jörres RA, Schulz H, et al. Direct and indirect costs of COPD and its comorbidities: results from the German COSYCONET study. Respir Med. 2016;111(39–46). doi:10.1016/j.rmed.2015.12.001
  • Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155–161. doi:10.1164/rccm.201201-0034OCrccm.201201-0034OC22561964
  • Wacker ME, Jörres RA, Karch A, et al. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies. Respir Res. 2016;17(81). doi:10.1186/s12931-016-0401-0
  • Graf J, Lucke T, Herrera R, et al. Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD. Pulm Pharmacol Ther. 2018;49(123–129). doi:10.1016/j.pupt.2018.01.011
  • Ingebrigtsen TS, Marott JL, Nordestgaard BG, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30:51–59. doi:10.1007/s11606-014-3029-025245885
  • Agh T, Inotai A, Meszaros A. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011;82:328–334. doi:10.1159/00032445321454953
  • Kokturk N, Polatli M, Oguzulgen IK, et al. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study. Int J Chron Obstruct Pulmon Dis. 2018;13:1377–1388. doi:10.2147/COPD.S15041129731625
  • Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28:437–443. doi:10.1592/phco.28.4.43718363527
  • Napolitano F, Napolitano P, Angelillo IF, Collaborative Working G. Medication adherence among patients with chronic conditions in Italy. Eur J Public Health. 2016;26:48–52. doi:10.1093/eurpub/ckv14726268628
  • Graf Jana JAR, Tanja L, Nowak Dennis VF. Claus. Medikamentöse Therapie der COPD. Deutsches Ärzteblatt. 2018;37:599–605.
  • Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–354.18453793
  • Montes de Oca M, Menezes A, Wehrmeister FC, et al. Adherence to inhaled therapies of COPD patients from seven Latin American countries: the LASSYC study. PLoS One. 2017;12:e0186777. doi:10.1371/journal.pone.018677729140978
  • Dekhuijzen R, Lavorini F, Usmani OS, van Boven JFM. Addressing the impact and unmet needs of nonadherence in asthma and chronic obstructive pulmonary disease: where do we go from here? J Allergy Clin Immunol Pract. 2018;6:785–793. doi:10.1016/j.jaip.2017.11.02729339126
  • Karch A, Vogelmeier C, Welte T, et al. The German COPD cohort COSYCONET: aims, methods and descriptive analysis of the study population at baseline. Respir Med. 2016;114:27–37. doi:10.1016/j.rmed.2016.03.00827109808
  • Lucke T, Herrera R, Wacker M, et al. Systematic analysis of self-reported comorbidities in large cohort studies - a novel stepwise approach by evaluation of medication. PLoS One. 2016;11:e0163408. doi:10.1371/journal.pone.016340827792735
  • Spitzer D. Marginal medicine. JAMA.1999;281:1082 author reply 1083. doi:10.1001/jama.281.12.1082
  • Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276. doi:10.1164/ajrccm.163.5.210103911316667
  • Krauskopf K, Federman AD, Kale MS, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD. 2015;12:151–164. doi:10.3109/15412555.2014.92206724960306
  • Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34:2940–2948. doi:10.1093/eurheartj/eht29523907142
  • Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32:725–737. doi:10.1111/dme.1265125440507
  • Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218–1224. doi:10.2337/diacare.27.5.121815111553
  • Vestbo J, Anderson JA, Calverley PMA, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64:939–943. doi:10.1136/thx.2009.11366219703830
  • Dhamane AD, Schwab P, Hopson S, et al. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:115–122. doi:10.2147/COPD.S11480228053521
  • Tamura G, Ohta K. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Respir Med. 2007;101:1895–1902. doi:10.1016/j.rmed.2007.05.00117587559
  • Bateman ED, Ferguson GT, Barnes N, et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J. 2013;42(1484–1494). doi:10.1183/09031936.00200212
  • Smid DE, Franssen FME, Gonik M, et al. redefining cut-points for high symptom burden of the global initiative for chronic obstructive lung disease classification in 18,577 patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2017;18:1097 e1011–1097 e1024. doi:10.1016/j.jamda.2017.09.003
  • Helmy R, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication Adherence Reporting Guidelines (EMERGE): a reactive-Delphi study protocol. BMJ Open. 2017;7:e013496. doi:10.1136/bmjopen-2016-013496

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.